Position in ERAS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$35,475,983
+$8,706,222 QoQ
Shares Held
1,936,462
+17.0% QoQ
Ownership
0.554%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#30
of 257 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. ERAS ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,173,152 | $1,079,469,792 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,682,932 | $206,501,997 | |
| 3 | INCY |
Incyte Corp
|
1,480,342 | $167,811,569 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
686,719 | $165,478,677 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
253,764 | $80,212,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
126,343 | $78,779,914 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
172,842 | $52,030,627 | |
| 8 | BNTX |
BioNTech SE
|
539,787 | $50,227,180 |
All Filings in ERAS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,475,983 | 1,936,462 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $26,769,761 | 1,654,497 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $68,414 | 18,391 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $40,399 | 18,532 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $24,321 | 19,151 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $27,002 | 19,710 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $50,742 | 20,216 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $57,545 | 21,079 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $50,690 | 21,479 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $24,287 | 11,790 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $26,872 | 12,616 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $19,946 | 10,125 | Shares | Sole | 2023-11-06 | |
| No filing history on record for this holder in this stock. | ||||||